Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|9|4|328-343
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.4, 2009-12, pp. : 328-343
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Genetic Vaccination for the Active Immunotherapy of Cancer
Current Gene Therapy, Vol. 1, Iss. 1, 2001-05 ,pp. :
Genetically Modified Dendritic Cells for Cancer Immunotherapy
Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. :
Cancer Immunotherapy Using Gene-Modified Dendritic Cells
Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. :
Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. :